In parallel, the marked reduction in CD163 expression, particularly in the NPIC and M1EVs + NPIC groups, reflects a decrease in immunosuppressive TAMs, which are known to facilitate tumor progression [69, 70]. The gene discussed is CD163; the disease is neoplasm.